Breaking News

GHO Capital Acquires Ardena

CDMO provides early stage drug development and manufacturing for small-to-mid sized biopharma.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, together with the existing management team has acquired Ardena, a specialist contract development and manufacturing organization (CDMO) focused on early phase drug development, from Mentha Capital.   Ardena is a multi-service CDMO, assisting small-to-mid sized biopharma with services spanning the full development life cycle. The company offers a comprehensive “Make, Analyze, File” model ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters